Martin E. Adelson, Ph.D. MDL Vice President and Director of Research & Development

• Ph.D. Graduate of the Fels Institute for Cancer Research and Molecular Biology at Temple University in Philadelphia, PA.
• Recipient of The Daniel Swern Memorial Fellowship.
• Postdoctoral work on HIV-1 based gene therapy at the University of Medicine and Dentistry of New Jersey.
• Recipient of a competitive Postdoctoral Fellowship from the National Lung and Blood Institute of the National Institute of Health entitled “Pseudotyped Lentiviral Vector Gene Therapy of Hemophilia”.
• Currently investigating co-infection aspects of Lyme Disease, participating in clinical pathogen prevalency studies with physicians and researchers in the New Jersey,
• Pennsylvania, and California areas, and developing new clinical diagnostic assays.
• Member of the American Society of Microbiology and the International Organization for Mycoplasmology, and the Association for Molecular Pathology.
• Guest reviewer for Infection and Immunity (2003), Clinical and Diagnostic Laboratory Immunology (2003), Applied and Environmental Microbiology (2003-2004), Clinical and Diagnostic Laboratory Immunology (2003-2004), Clinical and Diagnostic Microbiology (2003, 2005), Journal of Clinical Microbiology (2003-2007), Journal of Applied and Experimental Microbiology (2003-2004), and the Journal of Dermatological Science (2005), and Clinical Vaccine Immunology (2007).
• Appointed to the Editorial Board of the Journal of Clinical Microbiology (2005 -2008).
• Member of the Thomas Jefferson University Biotechnology Advisory Committee.